Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Biopharmaceuticals have provided a swift means of swelling pharmaceutical company pipelines, but they may not be such a fast “fix” for the industry in the future.
A new twist on DNA shuffling increases recombination frequency and expands access to sequence space, facilitating the engineering of new protein activities.
